Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis

被引:54
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
apoptosis; axonal damage; cerebrospinal fluid; cultured neurons; multiple sclerosis;
D O I
10.1016/S0165-5728(99)00225-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of axonal damage in multiple sclerosis (MS) has been recently stressed in proton magnetic resonance spectroscopy and pathological studies, but the exact mechanism producing this damage is unknown. The aim of our study was to ascertain whether soluble mediators present in the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS could induce neuron injury in culture. Different biochemical and cytochemical parameters were determined in primary embryonal rat neuron cultures following 8 days of exposure to CSF. Cytotoxic activity was evaluated with a blue formazan production colorimetric assay. Morphological and immunocytochemical studies performed with antibodies against beta-tubulin revealed neuritic fragmentation, axonal damage and cellular shrinkage indicating apoptosis, Detection of apoptosis was carried out using the fluorescent DNA-binding dye Hoechst 33342, as well as by a Terminal deoxynucleotidyl transferase-mediated dUTP Nick End-Labeling assay. We observed that soluble factors in CSF from patients with "aggressive" MS i.e, those with poor recovery after relapses, induced neurite breakdown and neuronal apoptosis in cultures. Neuron injury is not related with blood-brain barrier dysfunction nor with IgG index. Interestingly, CSF from patients with "non-aggressive" MS i.e., relapsing-remitting patients with a good recovery after relapses, did not induce any damage. In conclusion, we report that CSF from patients with aggressive MS bears soluble mediators that induce axonal damage and apoptosis of neurons in culture. These mediators can be present during the first attack of the disease, and the neuronal damage caused could be related to the functional deficit of these MS patients. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
[21]   Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study [J].
De Stefano, N ;
Matthews, PM ;
Fu, LQ ;
Narayanan, S ;
Stanley, J ;
Francis, GS ;
Antel, JP ;
Arnold, DL .
BRAIN, 1998, 121 :1469-1477
[22]   Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis [J].
Nocentini, U ;
Pasqualetti, P ;
Bonavita, S ;
Buccafusca, M ;
De Caro, MF ;
Farina, D ;
Girlanda, P ;
Le Pira, F ;
Lugaresi, A ;
Quattrone, A ;
Reggio, A ;
Salemi, G ;
Savettieri, G ;
Tedeschi, G ;
Trojano, M ;
Valentino, P ;
Caltagirone, C .
MULTIPLE SCLEROSIS, 2006, 12 (01) :77-87
[23]   Depression in relapsing-remitting multiple sclerosis [J].
Mendes, MF ;
Tilbery, CP ;
Balsimelli, S ;
Moreira, MA ;
Barao-Cruz, AM .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) :591-595
[24]   Relapsing-remitting tumefactive multiple sclerosis [J].
Selkirk, SM ;
Shi, J .
MULTIPLE SCLEROSIS, 2005, 11 (06) :731-734
[25]   Rituximab for relapsing-remitting multiple sclerosis [J].
He, Dian ;
Guo, Rui ;
Zhang, Fubo ;
Zhang, Chao ;
Dong, Shuai ;
Zhou, Hongyu .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12)
[26]   Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis [J].
Pavan, Karina ;
Marangoni, Bruna E. M. ;
Schmidt, Kizi B. ;
Cobe, Femanda A. ;
Matuti, Gabriela S. ;
Nishino, Lucia K. ;
Thomaz, Rodrigo B. ;
Mendes, Maria Fernanda ;
Lianza, Sergio ;
Tilbery, Charles Peter .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) :332-335
[27]   Natalizumab in relapsing-remitting multiple sclerosis [J].
Outteryck, Olivier .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) :471-481
[28]   Rituximab for relapsing-remitting multiple sclerosis [J].
He, Dian ;
Zhou, Hongyu ;
Han, Wenjie ;
Zhang, Shihong .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12)
[29]   Natalizumab for relapsing-remitting multiple sclerosis [J].
Horga, A. ;
Tintore, M. .
NEUROLOGIA, 2011, 26 (06) :357-368
[30]   Cerebrospinal Fluid Chloride Is Associated with Disease Activity of Relapsing-Remitting Multiple Sclerosis: A Retrospective Cohort Study [J].
Fang, Xingwei ;
Lu, Yaxin ;
Fu, Yongmei ;
Liu, Zifeng ;
Kermode, Allan G. ;
Qiu, Wei ;
Ling, Li ;
Liu, Chunxin .
BRAIN SCIENCES, 2023, 13 (06)